Journal
CLINICAL AND EXPERIMENTAL DERMATOLOGY
Volume 35, Issue 4, Pages 425-430Publisher
WILEY
DOI: 10.1111/j.1365-2230.2009.03611.x
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [30730083, 30671883]
- National Basic Research Program of China [2009CB825605]
- Hunan Natural Science Foundation [06C0049]
- Science Foundation of Hunan Province [06SK3033]
Ask authors/readers for more resources
P>Background. Impaired methylation of T-cell DNA is thought to contribute to the development of systemic lupus erythematosus (SLE). CD70 (TNFSF7) is a B-cell costimulatory molecule that contributes to excessive B-cell stimulation in vitro and in vivo. CD70 is overexpressed in CD4+ T cells of patients with SLE, and DNA demethylation occurs in promoter sequences that regulate CD70 expression in SLE CD4+ T cells. However, it is unknown whether the expression and methylation of CD70 in CD4+ T cells are affected in patients with subacute cutaneous lupus erythematosus (SCLE). Objective. To compare CD70 expression levels and the methylation status of the CD70 promoter region in CD4+ T cells from patients with SCLE and healthy controls. Methods. We used real-time RT-PCR to compare messenger RNA levels of CD70 and flow cytometry to compare CD70 protein levels in CD4+ T cells from patients with SCLE and healthy controls. Bisulphite sequencing was used to determine the methylation status of the CD70 promoter region. Results. CD70 is overexpressed at the surface of SCLE CD4+ T cells. Demethylation of the CD70 promoter region was seen in CD4+ T cells from patients with SCLE. Conclusions. Demethylation of regulatory elements contributes to CD70 overexpression in CD4+ T cells of patients with SCLE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available